Total number of publications: 25
2025
-
Therapeutic Drug Monitoring of Beta-Lactams in Cystic Fibrosis: Unattained Target in Standard Antibiotic Dosing: A Case Study
THERAPEUTIC DRUG MONITORING, year: 2025, volume: 47, edition: 5, DOI
2024
-
A pilot study of seminal plasma analysis in cystic fibrosis patients compared to a healthy population reveals significant changes in its composition.
Year: 2024, type: Conference abstract
-
A therapeutic piperacillin and meropenem serum concentration monitoring reveals suboptimal pharmacodynamic (PD) response in standard therapeutic regimes
Year: 2024, type: Conference abstract
-
Case report of two adults with F508del/3849+10 kb C > T genotype regaining exocrine pancreatic function following treatment with elexacaftor/tezacaftor/ivacaftor
Journal of Cystic Fibrosis, year: 2024, volume: 23, edition: 4, DOI
-
Improved Nutritional Outcomes and Gastrointestinal Symptoms in Adult Cystic Fibrosis Patients Treated with Elexacaftor/Tezacaftor/Ivacaftor
Digestive Diseases, year: 2024, volume: 42, edition: 4, DOI
-
The long-term effect of elexacaftor/tezacaftor/ivacaftor on cardiorespiratory fitness in adolescent patients with cystic fibrosis: a pilot observational study
BMC Pulmonary Medicine, year: 2024, volume: 24, edition: 1, DOI
2023
-
Co je nového v pneumologii - rok 2022
Vnitřní lékařství, year: 2023, volume: 69, edition: 5, DOI
-
Endobronchial cryobiopsy may shorten the time to cancer diagnosis: a retrospective study
ERJ open research, year: 2023, volume: 9, edition: 4, DOI
-
Impact of the elexacaftor/tezacaftor/ivacaftor on the nutrition parameters and gastrointestinal symptoms in adult cystic fibrosis patients in the cystic fibrosis centre of Brno, Czech Republic
Year: 2023, type: Conference abstract
-
Impact of the elexacaftor/tezacaftor/ivacaftor on the nutrition parameters and gastrointestinal symptoms in adult cystic fibrosis patients in the cystic fibrosis centre of Brno, Czech Republic
Year: 2023, type: Appeared in Conference without Proceedings